Investment

Details

Screening Program
Project Completed
 
  • RFP Year
    2015
  • Awarded Amount
    $132,000
  • Disease
    Tuberculosis
  • Intervention
    Drug
  • Development Stage
    Hit Identification
  • Collaboration Partners
    Mitsubishi Tanabe Pharma Corporation ,  The Global Alliance for TB Drug Development